Increased uric acid excretion could explain, at least in part, the renoprotective effects of SGLT2 inhibitors. The kidney-protective effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors in ...

Thursday, 22 January 2015--AstraZeneca today announced the European Medicines Agency has accepted the Marketing Authorisation Application (MAA) for lesinurad 200mg tablets. Lesinurad is a selective ...

TOKYO, Oct 8, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has received approval for "URECE Tablets" (dotinurad) in Thailand as a treatment for gout and hyperuricemia. This ...

The issue of elevated uric acid levels is becoming increasingly prevalent. As individuals age, the likelihood of developing conditions such as gout arthritis has been significantly noted. This ...